Bio
Jeffrey Smoot has been an information scientist at CAS for 30 years. Prior to joining CAS, Jeffrey held a research position with Northwestern University and was a Hematology-Oncology Fellow at The Ohio State University. He obtained a B.A. in chemistry and a B.S. in biology from the University of California, Irvine and a PhD. in Biochemistry from The Ohio State University.
Drug Discovery
Omicron variant accelerates need for more diverse COVID-19 vaccine strategy
Omicron's significant evolution from the original COVID-19 virus raises concerns about reinfection and vaccine evasion. This variant could potentially bypass existing immunity, threatening global pandemic recovery efforts. Explore the potential societal and economic impacts of this new challenge.
Read the CAS Insights article